0001401708-23-000214.txt : 20230905 0001401708-23-000214.hdr.sgml : 20230905 20230905163819 ACCESSION NUMBER: 0001401708-23-000214 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230901 FILED AS OF DATE: 20230905 DATE AS OF CHANGE: 20230905 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BEECHEM JOSEPH M CENTRAL INDEX KEY: 0001576195 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35980 FILM NUMBER: 231236355 MAIL ADDRESS: STREET 1: 530 FAIRVIEW AVENUE NORTH STREET 2: SUITE 2000 CITY: SEATTLE STATE: WA ZIP: 98109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NanoString Technologies Inc CENTRAL INDEX KEY: 0001401708 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 200094687 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 530 FAIRVIEW AVENUE NORTH CITY: SEATTLE STATE: WA ZIP: 98109 BUSINESS PHONE: 206-378-6266 MAIL ADDRESS: STREET 1: 530 FAIRVIEW AVENUE NORTH CITY: SEATTLE STATE: WA ZIP: 98109 4 1 wk-form4_1693946289.xml FORM 4 X0508 4 2023-09-01 0 0001401708 NanoString Technologies Inc NSTG 0001576195 BEECHEM JOSEPH M 530 FAIRVIEW AVENUE N SEATTLE WA 98109 0 1 0 0 SVP, Research & Development 0 Common Stock 2023-09-01 5 A 0 E 564 2.189 A 95017 D The purchase period ended September 1, 2023 for the Offering Period (as defined in the NanoString Technologies, Inc. Employee Stock Purchase Plan ("ESPP")) that began March 1, 2023. The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the ESPP, for the ESPP Purchase Period (as defined in the ESPP) of March 1, 2023 through September 1, 2023. This transaction is also exempt under Rule 16b-3(c). In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on September 1, 2023. /s/ Shannon Atchison, Attorney-in-fact 2023-09-05